About us
Platform
Mode of Action
Pipeline
Team
News
Contact us
Read our news articles
Avidicure Launches with $50 Million in Seed Financing
Read More
Avidity engineered multispecific antibodies that are highly efficacious in immune cell stimulation
Read More
